祥生医疗股价涨1%,中国路博迈基金旗下1只基金重仓,持有4.7万股浮盈赚取1.41万元

Company Overview - Xiangsheng Medical Technology Co., Ltd. is located in Wuxi, Jiangsu Province, and was established on January 30, 1996. The company went public on December 3, 2019. Its main business involves the research, development, manufacturing, and sales of ultrasound medical imaging equipment [1]. - The revenue composition of the company is as follows: 91.12% from ultrasound medical imaging equipment, 6.49% from accessories and others, 2.27% from technical service fees, and 0.12% from other sources [1]. Stock Performance - As of the latest report, Xiangsheng Medical's stock price increased by 1% to 30.29 CNY per share, with a trading volume of 8.7364 million CNY and a turnover rate of 0.26%. The total market capitalization is 3.396 billion CNY [1]. Fund Holdings - The fund "Lobomai China Medical Health Stock Initiation A" (020142) holds a significant position in Xiangsheng Medical, with 47,000 shares, accounting for 6.76% of the fund's net value, making it the fourth-largest holding [2]. - The fund was established on December 26, 2023, with a latest scale of 16.336 million CNY. Year-to-date returns are 17.51%, ranking 2966 out of 4195 in its category, while the one-year return is 15.01%, ranking 3086 out of 4179 [2]. - The fund manager, Li Tao, has been in charge for 2 years and 6 days, with a total asset scale of 22.8582 million CNY. The best and worst fund returns during his tenure are -5.15% and -6.31%, respectively [2].

CHISON MEDICAL-祥生医疗股价涨1%,中国路博迈基金旗下1只基金重仓,持有4.7万股浮盈赚取1.41万元 - Reportify